| Cadila Healthcare has signed a 50:50 joint venture (JV) agreemnt with Bharat Serums and Vaccines (BSVL) for the development, manufacturing and marketing of oncology products. This was announced in a release issued by Cadila Healthcare to the BSE today. |
Cadila, Bharat Serums sign 50:50 JV
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 16 2005 | 12:02 PM IST
